Gleamer

Gleamer is a French medtech company founded in 2017, specializing in artificial intelligence solutions for medical imaging, particularly in radiology. Headquartered in Paris, with a subsidiary in Boston and a presence in Germany, Gleamer aims to enhance diagnostic accuracy and reduce the workload of radiologists. In March 2026, the company was acquired by RadNet and became part of RadNet’s DeepHealth subsidiary.

Gleamer offers a range of AI-powered software solutions designed to assist radiologists and emergency physicians. Its flagship products include BoneView®, ChestView®, BoneMeasurement®, BoneAge®, and BreastView®, all of which are CE-marked and have received FDA clearance. These solutions are deployed in over 2,500 institutions across 45 countries, processing more than 35 million examinations annually. Gleamer's technology integrates seamlessly into clinical workflows, improving diagnostic accuracy and efficiency for healthcare professionals.